Slideshow

Nephritis Sets in Early in Lupus, Treatment Guidelines Can Stave Off Worsening Condition

By the time a patient is diagnosed with SLE, nephritis has already set in for 35 percent of patients. The American College of Rheumatology offers screening, treatment and management guidelines for lupus nephritis patients. In this slideshow, we review the options.

By the time a patient is diagnosed with systemic lupus erythematosus (SLE), nephritis has already set in for approximately 35 percent of patients. And, within 10 years, the number climbs to 50-60 percent of patients. The very presence of lupus nephritis reduces survival from 92 percent at 10 years to 88 percent, according to one estimate. The American College of Rheumatology offers screening, treatment and management guidelines for lupus nephritis patients. In this slideshow, we review the options.UPDATE:  First-Ever Treatment for Lupus Nephritis Wins FDA Approval 

References:

Hahn B, McMahon M, Wilkinson A, Wallace WD, Daikh D, Fitzgerald J, Karpouzas G, Merrill J, Wallace D, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi S, Gogia M, Kafaja S, Kamgar M, Lau C, Martin W, Parikh S, Peng J, Rastogi A, Chen W, Grossman J, American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care & Research (2012), doi: 10.1002/acr.21664

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
© 2024 MJH Life Sciences

All rights reserved.